menu
    • menu

    Company profile for Avacta Group

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to shape the future of medicine by developing safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer® platform. Avacta is developing novel cancer immunotherapies combining its two proprietary platforms - Affimer® biotherapeutics and tumour targeted chemotherapy. With this approach, the Company aims to address the lack of a durable response to current immunother...
    Our mission is to shape the future of medicine by developing safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer® platform. Avacta is developing novel cancer immunotherapies combining its two proprietary platforms - Affimer® biotherapeutics and tumour targeted chemotherapy. With this approach, the Company aims to address the lack of a durable response to current immunotherapies experienced by most patients. Avacta's proprietary targeted chemotherapy platform, releases active drug only in the tumour, thereby limiting systemic exposure and improving the overall safety.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avacta Groupunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Unit 20, Ash Way Thorp Arch Estate, Wetherby LS23 7FA
    Telephone
    Telephone
    +44 (0)1904 21 7070
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avacta.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/avacta-group-plc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/affimers?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avacta to Share New FAP Dox (AVA6000) Data at ESMO Congress
    Avacta to Share New FAP Dox (AVA6000) Data at ESMO Congress

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3123924/0/en/Avacta-to-Present-New-FAP-Dox-AVA6000-Data-at-the-European-Society-for-Medical-Oncology-ESMO-Congress.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    Avacta Appoints David Liebowitz as CMO and Yulii as Advisor
    Avacta Appoints David Liebowitz as CMO and Yulii as Advisor

    01 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/01/3108206/0/en/Avacta-Appoints-David-Liebowitz-M-D-Ph-D-as-Chief-Medical-Officer-and-Yulii-Bogatyrenko-as-Advisor-in-Business-Development.html

    GLOBENEWSWIRE
    01 Jul 2025
    Share Share
    Avacta Therapeutics Presents Data on FAP-Dox at 2025 AACR Meeting
    Avacta Therapeutics Presents Data on FAP-Dox at 2025 AACR Meeting

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069067/0/en/Avacta-Therapeutics-Presents-Data-from-Lead-pre-CISION-Candidate-FAP-Dox-AVA6000-at-the-2025-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Avacta Therapeutics Presents Data at 2025 AACR Annual Meeting
    Avacta Therapeutics Presents Data at 2025 AACR Annual Meeting

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069056/0/en/Avacta-Therapeutics-Presents-Preclinical-and-Translational-Data-from-pre-CISION-Platform-Candidates-at-2025-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Avacta's Business Update for Q1 2025 on Strategic Progress
    Avacta's Business Update for Q1 2025 on Strategic Progress

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052133/0/en/Avacta-Provides-Business-Update-for-the-First-Quarter-of-2025-Outlining-Progress-Against-Strategic-Objectives.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Avacta Therapeutics to Present at 2025 AACR Annual Meeting
    Avacta Therapeutics to Present at 2025 AACR Annual Meeting

    26 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/26/3049469/0/en/Avacta-Therapeutics-Announces-Presentations-at-2025-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    26 Mar 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search